BioCryst Pharmaceuticals, Inc. earnings per share and revenue

BCRX earnings per share for the last quarter are -0.07 USD whereas the estimation was -0.07 USD which accounts for -1.61% surprise. Company revenue for the same period amounts to 117.08 M USD despite the estimated figure of 113.99 M USD. Estimated earnings per share for the next quarter are -0.07 USD, and revenue is expected to reach 128.65 M USD. Also watch annual changes over time to get a bigger picture of BCRX earnings per share and revenue dynamics.